Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Klaria Pharma Holding AB: Klaria Interim Report

Klaria Pharma Holding
Download the release

Klaria interim report 1 January-31 March 2025

First quarter of 2024

The group in total

- Net sales 9.0 MSEK (0.1 MSEK)

- Other income 0.0 MSEK (0.0 MSEK)

- R&D expenses for the quarter amounted to 3.4 MSEK (4.6 MSEK)

- Profit after tax amounted to -1.6 MSEK (-11.9 MSEK)

- Earnings per share for the quarter amounted to -0.01 SEK (-0.11 SEK)

- Cash flow from operating activities amounted to 0.9 MSEK (-7.8 MSEK)

- Liquid assets on the balance sheet date amounted to 1.5 MSEK (0.9 MSEK)

- Equity as of March 31 amounted to 1.7 MSEK 29.2 MSEK)

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.